US20180117042A1 - Methods for treating respiratory syncytial virus infection - Google Patents

Methods for treating respiratory syncytial virus infection Download PDF

Info

Publication number
US20180117042A1
US20180117042A1 US15/795,079 US201715795079A US2018117042A1 US 20180117042 A1 US20180117042 A1 US 20180117042A1 US 201715795079 A US201715795079 A US 201715795079A US 2018117042 A1 US2018117042 A1 US 2018117042A1
Authority
US
United States
Prior art keywords
compound
pharmaceutically acceptable
acceptable salt
rsv
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/795,079
Inventor
Sushmita Mukherjee Chanda
John Fry
Lawrence M. Blatt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alios BioPharma Inc
Original Assignee
Alios BioPharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201662413801P priority Critical
Application filed by Alios BioPharma Inc filed Critical Alios BioPharma Inc
Priority to US15/795,079 priority patent/US20180117042A1/en
Assigned to ALIOS BIOPHARMA, INC. reassignment ALIOS BIOPHARMA, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHANDA, SUSHMITA MUKHERJEE, BLATT, LAWRENCE M., FRY, JOHN
Publication of US20180117042A1 publication Critical patent/US20180117042A1/en
Abandoned legal-status Critical Current

Links